Related Experiment Video
Updated: Jan 13, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
Published on: May 2, 2019
Non-cationic carriers for siRNA delivery: Current progress and potential applications.
Mengyu Fan1, Xinyue Yang1, Yang Liu1
1Henan Key Laboratory of Brain Targeted Bio-nanomedicine, Henan International Joint Laboratory of Nanobiomedicine, School of Life Sciences, Henan University, Kaifeng, Henan 475004, China.
Non-cationic carriers offer a safer alternative for delivering small interfering RNA (siRNA) therapeutics. These advanced delivery systems overcome the toxicity of traditional cationic carriers, paving the way for improved in vivo gene silencing applications.
Area of Science:
- Biotechnology
- Materials Science
- Pharmacology
Background:
- Small interfering RNA (siRNA) holds significant therapeutic promise for gene silencing but faces delivery challenges.
- Current cationic carriers exhibit cytotoxicity and immunogenicity, limiting clinical translation.
- Non-cationic carriers present a biocompatible alternative for effective siRNA delivery.
Purpose of the Study:
- To review recent advancements in non-cationic carriers for siRNA delivery.
- To explore various material types, loading strategies, and design principles.
- To discuss the clinical potential and future outlook of non-cationic siRNA delivery systems.
Main Methods:
- Review of recent scientific literature on non-cationic siRNA delivery systems.
- Categorization of carriers based on organic, inorganic, and biomimetic materials.
- Analysis of loading strategies, design considerations, and delivery mechanisms.
Main Results:
- Non-cationic carriers demonstrate enhanced biocompatibility compared to cationic counterparts.
- Diverse organic, inorganic, and biomimetic materials are being developed for siRNA encapsulation.
- Effective loading strategies and delivery mechanisms are crucial for therapeutic efficacy.
Conclusions:
- Non-cationic carriers are crucial for overcoming the limitations of current siRNA delivery systems.
- These carriers offer a promising avenue for developing safer and more effective gene silencing therapies.
- Further research into non-cationic carriers will advance the clinical application of siRNA therapeutics.
More Related Videos
08:31Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...